24-08-2016 14:15
via
feeds.reuters.com
BRIEF-Biopharmx enrolls first subject in OPAL Phase 2B clinical trial
* Biopharmx enrolls first subject in OPAL Phase 2B clinical
trial of bpx-01 topical minocycline for treatment of acne
Read more »